Industry: Medical Devices & Consumables
Published Date: 2026-01-09
Pages: 81 Pages
Report ld: 5646636
Request Sample
Customized Report
Percutaneous Surgical System Market Size(US$)

CAGR 2026-2032
5.8%
Market Size,2032
USD 526
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Percutaneous Surgical System was estimated to be worth US$ 358 million in 2025 and is projected to reach US$ 526 million, growing at a CAGR of 5.8% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Percutaneous Surgical System cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Percutaneous Surgical System involves minimally invasive techniques that allow procedures to be performed through small skin punctures or incisions. These systems utilize imaging technologies, such as ultrasound or fluoroscopy, to guide instruments and provide targeted treatment for conditions in various organs and tissues, reducing recovery time and minimizing trauma.
The North American market for Percutaneous Surgical System was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Percutaneous Surgical System was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Percutaneous Surgical System was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Percutaneous Surgical System market include Teleflex, B.Braun, Grena Ltd., Medtronic, Tuodao Medical, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Percutaneous Surgical System, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Percutaneous Surgical System market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Percutaneous Surgical System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Percutaneous Surgical System manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Percutaneous Surgical System sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Percutaneous Surgical System sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Percutaneous Surgical System Product Introduction
1.2 Global Percutaneous Surgical System Market Size Forecast
1.2.1 Global Percutaneous Surgical System Sales Value (2021–2032)
1.2.2 Global Percutaneous Surgical System Sales Volume (2021–2032)
1.2.3 Global Percutaneous Surgical System Sales Price (2021–2032)
1.3 Percutaneous Surgical System Market Trends & Drivers
1.3.1 Percutaneous Surgical System Industry Trends
1.3.2 Percutaneous Surgical System Market Drivers & Opportunities
1.3.3 Percutaneous Surgical System Market Challenges
1.3.4 Percutaneous Surgical System Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Percutaneous Surgical System Players Revenue Ranking (2025)
2.2 Global Percutaneous Surgical System Revenue by Company (2021–2026)
2.3 Global Percutaneous Surgical System Sales Volume Ranking of Players (2025)
2.4 Global Percutaneous Surgical System Sales Volume by Company (2021–2026)
2.5 Global Percutaneous Surgical System Average Price by Company (2021–2026)
2.6 Key Manufacturers Percutaneous Surgical System Manufacturing Base and Headquarters
2.7 Key Manufacturers Percutaneous Surgical System Product Offerings
2.8 Key Manufacturers Start of Mass Production of Percutaneous Surgical System
2.9 Percutaneous Surgical System Market Competitive Analysis
2.9.1 Percutaneous Surgical System Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Percutaneous Surgical System Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Percutaneous Surgical System revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Percutaneous Surgical System Market Classification
3.1 Introduction by Type
3.1.1 Percutaneous Needle Biopsy System
3.1.2 Percutaneous Catheter System
3.1.3 Others
3.1.4 Global Percutaneous Surgical System Sales Value by Type
3.1.4.1 Global Percutaneous Surgical System Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Percutaneous Surgical System Sales Value, by Type (2021–2032)
3.1.4.3 Global Percutaneous Surgical System Sales Value, by Type (%), 2021–2032
3.1.5 Global Percutaneous Surgical System Sales Volume by Type
3.1.5.1 Global Percutaneous Surgical System Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Percutaneous Surgical System Sales Volume, by Type (2021–2032)
3.1.5.3 Global Percutaneous Surgical System Sales Volume, by Type (%), 2021–2032
3.1.6 Global Percutaneous Surgical System Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Percutaneous Surgical System Sales Value by Application
4.2.1 Global Percutaneous Surgical System Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Percutaneous Surgical System Sales Value, by Application (2021–2032)
4.2.3 Global Percutaneous Surgical System Sales Value, by Application (%), 2021–2032
4.3 Global Percutaneous Surgical System Sales Volume by Application
4.3.1 Global Percutaneous Surgical System Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Percutaneous Surgical System Sales Volume, by Application (2021–2032)
4.3.3 Global Percutaneous Surgical System Sales Volume, by Application (%), 2021–2032
4.4 Global Percutaneous Surgical System Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Percutaneous Surgical System Sales Value by Region
5.1.1 Global Percutaneous Surgical System Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Percutaneous Surgical System Sales Value by Region (2021–2026)
5.1.3 Global Percutaneous Surgical System Sales Value by Region (2027–2032)
5.1.4 Global Percutaneous Surgical System Sales Value by Region (%), 2021–2032
5.2 Global Percutaneous Surgical System Sales Volume by Region
5.2.1 Global Percutaneous Surgical System Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Percutaneous Surgical System Sales Volume by Region (2021–2026)
5.2.3 Global Percutaneous Surgical System Sales Volume by Region (2027–2032)
5.2.4 Global Percutaneous Surgical System Sales Volume by Region (%), 2021–2032
5.3 Global Percutaneous Surgical System Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Percutaneous Surgical System Sales Value, 2021–2032
5.4.2 North America Percutaneous Surgical System Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Percutaneous Surgical System Sales Value, 2021–2032
5.5.2 Europe Percutaneous Surgical System Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Percutaneous Surgical System Sales Value, 2021–2032
5.6.2 Asia Pacific Percutaneous Surgical System Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Percutaneous Surgical System Sales Value, 2021–2032
5.7.2 South America Percutaneous Surgical System Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Percutaneous Surgical System Sales Value, 2021–2032
5.8.2 Middle East & Africa Percutaneous Surgical System Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Percutaneous Surgical System Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Percutaneous Surgical System Sales Value and Sales Volume
6.2.1 Key Countries/Regions Percutaneous Surgical System Sales Value, 2021–2032
6.2.2 Key Countries/Regions Percutaneous Surgical System Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Percutaneous Surgical System Sales Value, 2021–2032
6.3.2 United States Percutaneous Surgical System Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Percutaneous Surgical System Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Percutaneous Surgical System Sales Value, 2021–2032
6.4.2 Europe Percutaneous Surgical System Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Percutaneous Surgical System Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Percutaneous Surgical System Sales Value, 2021–2032
6.5.2 China Percutaneous Surgical System Sales Value by Type (%), 2025 vs 2032
6.5.3 China Percutaneous Surgical System Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Percutaneous Surgical System Sales Value, 2021–2032
6.6.2 Japan Percutaneous Surgical System Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Percutaneous Surgical System Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Percutaneous Surgical System Sales Value, 2021–2032
6.7.2 South Korea Percutaneous Surgical System Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Percutaneous Surgical System Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Percutaneous Surgical System Sales Value, 2021–2032
6.8.2 Southeast Asia Percutaneous Surgical System Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Percutaneous Surgical System Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Percutaneous Surgical System Sales Value, 2021–2032
6.9.2 India Percutaneous Surgical System Sales Value by Type (%), 2025 vs 2032
6.9.3 India Percutaneous Surgical System Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Teleflex
7.1.1 Teleflex Company Information
7.1.2 Teleflex Introduction and Business Overview
7.1.3 Teleflex Percutaneous Surgical System Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Teleflex Percutaneous Surgical System Product Offerings
7.1.5 Teleflex Recent Developments
7.2 B.Braun
7.2.1 B.Braun Company Information
7.2.2 B.Braun Introduction and Business Overview
7.2.3 B.Braun Percutaneous Surgical System Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 B.Braun Percutaneous Surgical System Product Offerings
7.2.5 B.Braun Recent Developments
7.3 Grena Ltd.
7.3.1 Grena Ltd. Company Information
7.3.2 Grena Ltd. Introduction and Business Overview
7.3.3 Grena Ltd. Percutaneous Surgical System Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Grena Ltd. Percutaneous Surgical System Product Offerings
7.3.5 Grena Ltd. Recent Developments
7.4 Medtronic
7.4.1 Medtronic Company Information
7.4.2 Medtronic Introduction and Business Overview
7.4.3 Medtronic Percutaneous Surgical System Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Medtronic Percutaneous Surgical System Product Offerings
7.4.5 Medtronic Recent Developments
7.5 Tuodao Medical
7.5.1 Tuodao Medical Company Information
7.5.2 Tuodao Medical Introduction and Business Overview
7.5.3 Tuodao Medical Percutaneous Surgical System Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Tuodao Medical Percutaneous Surgical System Product Offerings
7.5.5 Tuodao Medical Recent Developments
8 Industry Chain Analysis
8.1 Percutaneous Surgical System Industrial Chain
8.2 Percutaneous Surgical System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Percutaneous Surgical System Sales Model
8.5.2 Sales Channels
8.5.3 Percutaneous Surgical System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Percutaneous Surgical System market is projected to grow from US$ 358 million in 2025 to US$ 526 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 124
USD 4900.00
(Single User License)
The global Percutaneous Surgical System market size was US$ 358 million in 2025 and is forecast to reach a readjusted size of US$ 526 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 71
USD 4250.00
(Single User License)
The global Percutaneous Surgical System market was valued at US$ 358 million in 2025 and is anticipated to reach US$ 526 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 106
USD 2900.00
(Single User License)
The global Percutaneous Surgical System market is projected to grow from US$ 340 million in 2024 to US$ 500 million by 2031, at a CAGR of 5.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 113
USD 4900.00
(Single User License)
The global Percutaneous Surgical System market size was US$ 340 million in 2024 and is forecast to a readjusted size of US$ 500 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 65
USD 4250.00
(Single User License)
The global market for Percutaneous Surgical System was estimated to be worth US$ 340 million in 2024 and is forecast to a readjusted size of US$ 500 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 87
USD 3950.00
(Single User License)
The global market for Percutaneous Surgical System was valued at US$ 340 million in the year 2024 and is projected to reach a revised size of US$ 500 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published Date: 2025-03-10
Pages: 70
USD 2900.00
(Single User License)
Percutaneous Surgical System involves minimally invasive techniques that allow procedures to be performed through small skin punctures or incisions. These systems utilize imaging technologies, such as ultrasound or fluoroscopy, to guide instruments and provide targeted treatment for conditions in various organs and tissues, reducing recovery time and minimizing trauma.
Published Date: 2024-09-06
Pages: 67
USD 2900.00
(Single User License)
Percutaneous Surgical System involves minimally invasive techniques that allow procedures to be performed through small skin punctures or incisions. These systems utilize imaging technologies, such as ultrasound or fluoroscopy, to guide instruments and provide targeted treatment for conditions in various organs and tissues, reducing recovery time and minimizing trauma.
Published Date: 2024-09-06
Pages: 114
USD 4900.00
(Single User License)
Percutaneous Surgical System involves minimally invasive techniques that allow procedures to be performed through small skin punctures or incisions. These systems utilize imaging technologies, such as ultrasound or fluoroscopy, to guide instruments and provide targeted treatment for conditions in various organs and tissues, reducing recovery time and minimizing trauma.
Published Date: 2024-09-06
Pages: 99
USD 4350.00
(Single User License)
The global Percutaneous Surgical System market is projected to grow from US$ 358 million in 2025 to US$ 526 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 124
The global Percutaneous Surgical System market size was US$ 358 million in 2025 and is forecast to reach a readjusted size of US$ 526 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 71
The global Percutaneous Surgical System market was valued at US$ 358 million in 2025 and is anticipated to reach US$ 526 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 106
The global Percutaneous Surgical System market is projected to grow from US$ 340 million in 2024 to US$ 500 million by 2031, at a CAGR of 5.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 113
The global Percutaneous Surgical System market size was US$ 340 million in 2024 and is forecast to a readjusted size of US$ 500 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 65
The global market for Percutaneous Surgical System was estimated to be worth US$ 340 million in 2024 and is forecast to a readjusted size of US$ 500 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 87
The global market for Percutaneous Surgical System was valued at US$ 340 million in the year 2024 and is projected to reach a revised size of US$ 500 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published: 2025-03-10
Pages: 70
Percutaneous Surgical System involves minimally invasive techniques that allow procedures to be performed through small skin punctures or incisions. These systems utilize imaging technologies, such as ultrasound or fluoroscopy, to guide instruments and provide targeted treatment for conditions in various organs and tissues, reducing recovery time and minimizing trauma.
Published: 2024-09-06
Pages: 67
Percutaneous Surgical System involves minimally invasive techniques that allow procedures to be performed through small skin punctures or incisions. These systems utilize imaging technologies, such as ultrasound or fluoroscopy, to guide instruments and provide targeted treatment for conditions in various organs and tissues, reducing recovery time and minimizing trauma.
Published: 2024-09-06
Pages: 114
Percutaneous Surgical System involves minimally invasive techniques that allow procedures to be performed through small skin punctures or incisions. These systems utilize imaging technologies, such as ultrasound or fluoroscopy, to guide instruments and provide targeted treatment for conditions in various organs and tissues, reducing recovery time and minimizing trauma.
Published: 2024-09-06
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now